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ABSTRACT  
 
Background and Aims Smoking is the largest preventable cause of death in the UK 
and imposes a huge economic burden on society. Both smoking prevalence and the 
heaviness of smoking are significantly higher among people with mental disorders 
than among the general population. The aim of this study is to estimate the economic 
costs of the health effects of cigarette smoking amongst people with mental disorders 
in the UK from a societal perspective.   
  
Methods This study follows the World Health Organization’s economics of tobacco 
toolkit to assess the economic costs of the health effects of cigarette smoking among 
people with mental disorders in 2009/10 in the UK. Based on the cost of illness 
approach, direct healthcare costs, indirect morbidity costs and indirect mortality costs 
due to smoking-related diseases were calculated to estimate the avoidable economic 
burden of smoking in people with mental disorders. 
  
Results The estimated economic cost of smoking in people with mental disorders was 
£2.34 billion in 2009/10 in the UK. About £719 million (31% of the total cost) was 
spent in this time period on treating diseases caused by smoking amongst people with 
mental health disorders. Productivity losses due to smoking-related diseases were 
about £823 million (35%) for work-related absenteeism and £797 million (34%) 
associated with premature mortality.    
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Conclusions Smoking in people with mental disorders in the UK imposes significant 
economic costs. The development and implementation of smoking cessation 
interventions in this group should therefore be a high economic and clinical priority. 
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INTRODUCTION  
 
Treatments for mental health disorders and smoking-related diseases account for 
substantial expenditure in all health care systems. At any time in the UK about one in 
six adults has a mental health disorder, typically anxiety, depression or schizophrenia, 
whilst the prevalence of smoking in this group, at 33% in 2007, is around 50% higher 
than in the general population [1]. Since people with mental health disorders are also 
more likely to smoke heavily,[2] this group accounts for as much as 42% of total 
national tobacco consumption.[1] 
 
In 2009/10 the economic cost to society of mental health disorders in the UK was 
approximately £105 billion.[3] Mental health services account for about 14% of the 
total annual National Health Service (NHS) budget and is the largest single category 
of NHS expenditure. Smoking is the leading avoidable cause of ill-health and 
premature mortality in the UK, and the cost of smoking-related ill-health to the NHS 
is approximately £5.17 billion, or 5.5% of the total NHS budget.[4] The high 
prevalence of smoking among people with mental health disorders makes the most 
common smoking-related illnesses, especially lung cancer, cardiovascular disease and 
chronic obstructive pulmonary disease (COPD),[5] particularly prevalent in this 
group, and these conditions account for much of the reduced life expectancy of people 
with mental health disorders.[6] This morbidity and mortality, and the economic costs 
that ensue, are entirely avoidable.  
 
The high prevalence of smoking among people with mental health disorders, and the 
significant contribution that smoking makes to the increased morbidity and mortality 
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in this group, has been extensively documented and reflects the effects of an historical 
smoking culture within mental healthcare settings, smoking being used as a form of 
self-mediation by patients and control by staff,  and a lack of awareness of smoking as 
an issue among professionals working with or caring for people with mental 
disorders.[6] The economic disadvantage experienced by many people with mental 
disorders as a result of unemployment and dependence on state benefits is also 
exacerbated by expenditure on smoking, which may further exacerbate ill-health.   
 
Despite the significant health and financial impacts of smoking in this population 
there has been little research with regard to the economic burden. Improved 
understanding of the economic cost of smoking and its major determinants helps to 
inform policymakers and to motivate decisions to reduce the smoking rate and 
burden. The aim of this study is to estimate the economic costs of the health effects of 
cigarette smoking amongst people with mental disorders in the UK. This study was 
carried out as part of a wider assessment of the health effects of smoking among 
people with mental health disorders commissioned by the Royal College of 
Physicians.[6] 
 
METHOD  
 
Based on the cost of illness approach, the avoidable economic burden of smoking in 
people with mental health disorders comprises three components: direct healthcare 
costs, indirect morbidity costs and indirect mortality costs due to smoking-related 
diseases.[7] The target population in this study focuses on UK adults aged 16 and over 
with any mental health diagnosis. Costs were assessed from the NHS and Personal 
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Social Services (PSS) perspective. All costs were estimated in UK pounds (£) in the 
2009/10 financial year. The Hospital and Community Health Services (HCHS) Pay 
and Prices Index was used to inflate cost estimates from other time periods.[8]  
  
Prevalence of mental disorders and smoking rates 
 
Mental health disorders are usually categorised into two groups. Neurotic disorders 
(common mental disorder/CMD) consist of mixed anxiety/depressive disorder, 
generalised anxiety disorder, depressive episodes, any phobia, obsessive compulsive 
disorder and panic disorder. Psychotic disorders (severe mental health 
disorders/SMD) include schizophrenia and affective psychosis, such as bi-polar 
disorder. 
 
Table 1 summarises the prevalence of mental disorders and the prevalence of current, 
ex- and never smoking among adults in the UK with these conditions. The prevalence 
of each mental health disorder was taken from the 2007 Adult Psychiatric Morbidity 
Survey (APMS),[1] and the prevalence of current smoking and ex-smoking for those 
with neurotic disorders from the study by Coulthard et al.[9] It is more difficult to 
obtain data for people with psychotic disorders in national surveys of the general 
population as many live in institutions or are homeless; however, a survey of residents 
in psychiatric institutions conducted by Meltzer and colleagues in 1996 reported that 
over 70% of residents were smokers and the highest smoking rates (78%) were found 
among males diagnosed with schizophrenia.[2] 
 
Table 1: Prevalence of mental disorders and associated smoking status   
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Diagnosis of Mental health illness 
Prevalence of  
condition a   
Current Smokersb,c Former Smokersb,c 
Male        
Neurotic disorder / Common mental 
disorders (CMDs) 
   
Mixed anxiety and depressive disorder 6.9% 45% 23% 
Generalised anxiety disorder 3.4% 43% 24% 
Depressive episode 1.9% 55% 17% 
All phobias 0.8% 67% 7% 
Obsessive compulsive disorder 0.9% 52% 23% 
Panic disorder 1.0% 12% 8% 
Any Neurotic disorder 12.5% 46% 23% 
        
Psychotic disorder / Severe mental 
health disorders (SMDs)  
   
Schizophrenia delusional  0.4% 78% 9% 
Affective psychosis 0.4% 70% 5% 
Female        
Neurotic disorder / Common mental 
disorders (CMDs) 
   
Mixed anxiety and depressive disorder 11.0% 39% 14% 
Generalised anxiety disorder 5.3% 45% 15% 
Depressive episode 2.8% 53% 16% 
All phobias 2.0% 45% 19% 
Obsessive compulsive disorder 1.3% 56% 19% 
Panic disorder 1.2% 40% 23% 
Any Neurotic disorder 19.7% 42% 15% 
        
Psychotic disorder / Severe mental health 
disorders (SMDs)  
   
Schizophrenia delusional  0.4% 62% 9% 
Affective psychosis 0.4% 70% 5% 
a. Source of prevalence of mental disorders: Adult psychiatric morbidity in England, 2007.[1]    
b. Source of smoking prevalence for CMDs: Tobacco, alcohol and drug use and mental health in Social Survey Division of the 
Office for National Statistics.[9] 
c. Source of smoking prevalence for SMDs:	 Office of Population Censuses and Surveys (OPCS) Surveys of Psychiatric 
Morbidity in Great Britain, Report 6.[2] 
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Smoking-attributable proportion 
 
To estimate the ensuing economic costs for smoking related diseases we have used the 
attributable risk approach originally devised by Levin,[10] and widely used in 
estimation of smoking-attributable health outcomes in the literature. The smoking-
attributable proportion (SAP) of disease in current and former smokers compared to 
never-smokers can be estimated from the relative risks of disease and prevalence of 
exposure using the formula (I):   
 SAP = !!"# !!"#!! !!!" !!"!!      !! !!"# !!"#!! !!!" !!"!!        (I) 
 
Where:  
SAP  = smoking attributable proportion  
pcur  = proportion who are current smokers  
rcur  = relative risk for current compared with never smokers  
pex  = proportion who are ex-smokers  
rex  = relative risk for ex compared with never smokers 
 
SAP quantifies the fraction of total costs incurred as a consequence of smoking. The 
SAP is used to compute both direct medical costs and indirect productivity losses in 
the following sections.  
 
Direct medical costs  
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Direct medical costs are defined as the monetary value of resources consumed as a 
result of treating smoking-related disease. In this study, direct healthcare costs 
included costs of hospital admissions, outpatient visits, general practitioner (GP) and 
practice nurse consultations and prescriptions related to smoking-related diseases 
among people with mental disorders. The costs of each healthcare service attributable 
to smoking were calculated using the following equation (II).    
  𝑆𝐴𝐶! = 𝑆𝐴𝑃!"#$ ∗ 𝑇𝐻𝑄!"# ∗ 𝑈𝐶! (II) 
Where 
SACi   = smoking-attributable costs of healthcare service type i, which includes inpatient 
hospitalizations, outpatient visits, GP and practice nurse consultations and prescriptions.  
SAPijkl = smoking attributable proportion of healthcare service i utilisation for treating smoking-related 
disease j among people with mental disorder k by gender l 
THQij = the quantity of total healthcare utilisation for treating a disease j on healthcare service type i by 
gender l among people with mental disorders 
UCi = Unit cost of the healthcare service type i 
 
The first component of direct medical costs caused by smoking was hospital 
admission costs. Tables A1 and A2 in the appendix list fatal and non-fatal diseases 
caused by smoking, their International Classification of Diseases (ICD  -10) codes, 
and the relative risks for developing each disease for current and former smokers 
compared with never smokers, by gender.[11] The number of hospital inpatient 
episodes was measured by the number of hospital admissions (finished consultant 
episodes, FCEs) derived from the Hospital Episode Statistics (HES) for England 
during the period April 2009 to March 2010.[12] Average costs for finished consultant 
episodes by types of smoking-related diseases were taken from the relevant 
Healthcare Resource Groups (HRG4) in 2009-10 NHS Reference Costs.[13] 
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Similarly, relative risks of outpatient and primary care utilisation by current smokers 
and ex-smokers compared to never smokers are listed in Table A3 (Appendix). The 
data were obtained from reports of health service use and the UK General Household 
Survey in 2006.[14] 
 
There were 926.7 million prescription items dispensed in 2010 and the average net 
ingredient cost (NIC) per prescription item was £9.53.[15] It is reported that 62% of 
consultations were conducted by GPs and 34% were undertaken by practice nurses 
[16]. Unit costs of GP and nurse visits were sourced from the Personal Social Services 
Research Unit (PSSRU) Unit Costs 2010, with a cost of £32 per GP consultation and 
£10 per practice nurse consultation [8]. In 2009/10, the number of outpatient 
attendances for adults aged 16 and over was 27 million for males and 21 million for 
females. The average cost of an adult outpatient visit in 2009/10 was £98[13]. 
 
The cost of outpatient and primary care utilisation for other UK jurisdictions were 
extrapolated from the estimates for England using 2010 population estimates where 
published data were not available [17, 18].   
 
Indirect morbidity costs 
 
The indirect costs of smoking among people with mental disorders were estimated 
using the human capital approach [7]. Cigarette smokers are more likely to be absent 
from work due to various smoking-related diseases compared to never-smokers [19]. 
In this study, the indirect morbidity costs of smoking were estimated as the economic 
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value of lost productivity from increased rates of absenteeism associated with 
smoking using equation (III). 
 𝑆𝐴𝐼 = 𝑆𝐴𝑃!"# ∗ 𝑇𝑊𝐿𝐷!" ∗ 𝐸𝑅𝑁 (III) 
 
Where 
SAI = smoking-attributable indirect morbidity costs from the productivity losses due to smoking-
related diseases 
SAPikl = smoking attributable proportion of indirect morbidity costs for smoking-related disease j 
among people with mental disorder k by gender l 
TWLDjk = total yearly work-loss days due to disease j among population subgroup k by gender l 
ERN = average national daily earnings   
 
Smoking-attributable costs of work days lost were calculated by multiplying smoking-
attributable work days lost by average income. The Office for National Statistics 
report that the employment rate for people with a common mental disorder was 57% 
in 2000, in which 40% are working full time and a further 17% working part time. 
Among people with severe mental disorders, only 9% work full time and 19% work 
part time.[20] The mean number of days absent from work in the past year for people 
with common and severe mental disorders were reported as 19 days and 67 days 
respectively.[20] A recently-published systematic review reported that the relative risk 
of absence for current smokers versus never-smokers was 1.33 (95% CI: 1.25 – 1.41) 
and the relative risk of absenteeism for ex-smokers versus never-smokers was 1.14 
(95% CI: 1.08 – 1.21) [21]. Average earnings in the UK were used to value 
productivity losses due to smoking-related diseases as reported in an annual survey of 
hours and earning by the Office for National Statistics [22] 
 
	12	
	
Indirect mortality costs 
 
A further aspect of the economic cost of smoking is the value of smoking-attributable 
lost productivity from premature death. In this study, years of potential life lost 
(YPLL) were estimated to present the years lost that a smoker would have lived had 
they not smoked. Years of potential working life lost (YPWLL) and years of potential 
total life lost (YPTLL) for smokers with mental disorders were estimated based on 
data obtained from the mortality statistics in 2010 reported by the Office of National 
Statistics (2010b) [23]. Studies have reported higher mortality in people with mental 
disorders compared to the rest of the population.[24] (Thompson, 2013) The relative 
risks of mortality for different causes of death (by ICD-10 categories) that compare 
people with mental disorders to the general population were obtained from a Mental 
Health Minimum Data Set (MHMDS) report.[24] Furthermore, NHS England report 
life expectancies around 10 years shorter in people with mental disorders compared to 
the general population, particularly in those with severe mental disorders where life 
expectancy may be up to 25 years shorter. However, due to the lack of UK-specific 
data the longevity difference reported by Lawrence et al was used in this study.[25]  
 
Indirect mortality costs were calculated to present the monetary value of lives lost due 
to smoking-attributable premature death among people with mental disorder. The 
indirect mortality cost was calculated by taking the net present value of future 
productivity (PVFP) using the following equation (IV) [7]. 
 SAM = 𝑆𝐴𝑃!!"# ∗  𝑁𝐷𝐸𝐴𝑇𝐻!"# ∗ PVLE!" (IV) 
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Where  
SAM = smoking-attributable mortality cost 
SAPjkml = smoking attributable proportion of indirect morbidity costs for smoking-related disease j 
among people with mental disorder k, by different age-group m and gender l 
NDEATHjml = number of death from disease j for population subgroup, by different age-group m and 
gender l 
PVLEml = total discounted present value of lifetime earnings for population subgroup, by different age-
group m and gender l 
 
The number of deaths from smoking-attributable diseases was estimated for males 
and females separately using 10-year age groups. The number of deaths was then used 
to estimate residual years of working life by subtracting age at death from retirement 
age (65 years). The next step was to attach the average earnings to the remaining 
working years and adjust the income into present values, adopting a discount rate of 
3.5% following National Institute for Health and Care Excellence (NICE) 
guidelines.[26] 
 
RESULTS 
 
An estimated 3 million adults aged 16 and over with mental disorders were smokers 
in the 2009/10 financial year in the UK.[6] The total smoking-attributable costs were 
estimated at £2.34 billion in 2009/10 in the UK (Table 2). Costs are distributed 
approximately equally between the three cost components. Approximately £719 
million (31%) was spent each year on treating diseases caused by smoking amongst 
people with mental health disorders. Productivity losses due to smoking-related 
diseases were estimated to be £823 million (35%) for work-related absenteeism and 
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£797 million (34%) associated with premature mortality.   
 
Table 2 Total economic costs of smoking in people with mental disorders, UK, 2009/10 (£ million) 
Cost component Male Female All Adults 
Direct medical costs £319 (30%) £400 (31%) £719 (31%) 
Indirect morbidity costs £333 (31%) £490 (38%) £823 (35%) 
Indirect mortality costs £415 (39%) £383 (30%) £797 (34%) 
Total costs £1,066 (100%) £1,273 (100%) £2,340 (100%) 
 
Direct medical costs  
 
Table 3 lists the cost components of NHS direct medical costs for treating diseases 
caused by smoking among people with mental health disorders in 2009/10. The 
overall estimated cost to the NHS was £719 million; approximately half (£352 million) 
was due to hospital admissions. The majority (90%) of excess expenditure of hospital 
admissions due to smoking were costs associated with treating malignant neoplasms 
(£111 million), cardiovascular diseases (£109 million) and respiratory diseases (£95 
million). Smoking-attributable costs for hospital admissions for treatment of non-fatal 
diseases were approximately £28 million. Total hospital admission costs for males 
and females were £186 million (53%) and £166 million (47%), respectively.   
 
Table 3: Health care expenditure attributable to smoking in people with mental disorder by type of 
service, UK 2009/10 Unit: £million 
  Male Female  All Adults 
Total cost of  hospital admission £186.46 £165.73 £352.19 
Malignant Neoplasms £46.13 £64.52 £110.66 
Cardiovascular Diseases £56.22 £52.48, £108.70 
Respiratory Diseases £58.07 £36.88 £94.95 
Digestive Diseases £5.30 £4.96, £10.23 
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Non-fatal diseases £20.74 £6.92 £27.65 
Cost of GP consultations  £41.07 £61.18 £102.26 
Cost of Practice nurse consultations £5.72 £8.28 £14.01 
Cost of GP prescriptions £70.71 £108.27 £178.98 
Cost of Outpatient attendances £35.18 £36.06 £71.24 
Total direct medical costs £318.42 £400.26 £718.68 
 
Consultations with GPs and practice nurses due to smoking in mental health cost the 
NHS £116 million in 2009/10. An estimated 18.8 million prescriptions were issued by 
GPs to treat smoking-related diseases among people with mental disorders and 
generated a cost of £179 million to the NHS. The estimated cost of outpatient 
attendances attributable to smoking was £71 million which accounted for 10% of all 
direct medical costs for people with mental health disorders.  
 
Indirect morbidity costs 
 
The annual productivity loss due to excess absenteeism associated with smoking 
attributable morbidity in the UK was estimated at approximately £823 million among 
people suffering from mental health disorders in 2009/10. Table 4 lists employment 
status and average weekly earnings for people with and without mental disorders.  
 
Table 4 Employment status and average weekly pay for people with and without 
mental disorders  
 
People with CMDs People with SMDs 
People without mental 
disorders 
Employment status 
Working full time 40% 9% 50% 
Working part time 17% 19% 19% 
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Unemployed 4% 2% 2% 
Economically inactive 39% 70% 29% 
 Average weekly pay (at 2010 price) 
Full time male £594 £441 £653 
Full time female £467 £347 £513 
Part time male  £190 £141 £209 
Part time female  £177 £131 £195 
 
Table 5 Indirect morbidity costs attributable to smoking in people with mental disorders by type of 
mental disorders, UK 2009/10 Unit: £ million 
Diagnosis of mental health illness Male Female All 
Neurotic disorder / Common mental disorders 
(CMDs) 
   
Mixed anxiety and depressive disorder £156 (46.8%) £207 (42.2%) £363 (44.1%) 
Generalised anxiety disorder £75 (22.5%) £112 (22.8%) £187 (22.7%) 
Depressive episode £48 (14.4%) £67 (13.7%) £115 (14.0%) 
All phobias £22 (6.7%) £43 (8.9%) £66 (8.0%) 
Obsessive compulsive disorder  £23 (6.8%) £33 (6.7%) £56 (6.7%) 
Panic disorder £7 (2.1%) £25 (5.0%) £32 (3.9%) 
Psychotic disorder       
Schizophrenia delusional   £2 (0.5%) £2 (0.4%) £4 (0.4%) 
Affective psychosis £1 (0.3%) £1 (0.2%) £2 (0.2%) 
Total £333 (100%) £490 (100%) 823 (100%) 
 
Table 5 presents indirect morbidity cost estimates by diagnosis and gender. Costs 
incurred due to lost economic productivity attributable to smoking were £333 million 
for males and £490 million for females with mental illnesses. Of the total £823 
million of indirect morbidity costs, about 44% (£363 million) are incurred by people 
with mixed anxiety and depressive disorder which is the most prevalent mental 
disorder in the population whilst generalised anxiety disorder and depressive episode 
cost £187 million (23%) and £115 million (14%) respectively. Only a very small 
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proportion (£6 million, 0.6%) of indirect costs was incurred by people with severe 
mental disorders as only 28% are able to maintain regular work (9% full time and 19% 
part time).  
 
Indirect mortality cost 
 
Table 6 summarises the years of potential working life lost (YPWLL) as a 
consequence of smoking for both males and females with mental disorders with a 
‘cut-off’ age of 65 (retiring age), and years of potential total life lost (YPTLL) with a 
‘cut-off’ age of 85. Overall, there were a total of 35,228years of potential working 
years of life lost in people with mental illness in the UK in 2010, 23,827for males and 
11,400 for females. The estimated total life years lost due to smoking-related diseases 
were 192,005years (121,921for males and 70,085 among females). 
  
Table 6 Smoking attributable years of potential life lost (YPLL) and indirect mortality cost among 
people with mental disorders in UK, 2009/10 
Diagnosis of Mental 
health illness 
Years of 'working life' lost  Years of 'total life' lost 
Indirect mortality cost  
(£ million) 
 
Male Female All Male Female All Male Female All 
Neurotic disorder / Common mental disorders (CMDs) 
Mixed anxiety and 
depressive disorder 
11,157 5,063 16,219 57,051 31,188 88,239 £195 £171 £366 
Generalised anxiety 
disorder 
5,430 2,612 8,042 27,793 16,048 43,841 £95 £88 £183 
Depressive episode 3,235 1,532 4,767 16,480 9,383 25,863 £57 £52 £109 
All phobias 1,425 618 2,043 7,236 3,800 11,035 £25 £21 £46 
Obsessive 
compulsive disorder 
1,521 739 2,260 7,752 4,523 12,275 £27 £25 £52 
Panic disorder 876 751 1,628 4,677 4,628 9,306 £15 £25 £40 
Psychotic disorder           
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Schizophrenia 
delusional  
112 50 162 566 306 871 £0.5 £0.4 £0.9 
Affective psychosis 72 34 106 365 209 574 £0.3 £0.3 £0.6 
Total 23,827 11,400 35,228 121,921 70,085 192,005 £415 £383 £797 
 
Table 6 also reports the economic cost of premature mortality caused by smoking-
related diseases. Deaths from smoking in people with mental disorders were estimated 
to result in the loss of around £797 million in the UK in 2009/10 and over half (52%) 
of mortality costs were incurred by male smokers. Nearly 50% (£366 million) of 
indirect costs were associated with people who have mixed anxiety and depressive 
disorder, followed by smokers with generalised anxiety disorder (23%).  
 
Table 7 shows the number of premature deaths caused by smoking and the indirect 
mortality cost among people with mental health disorders by smoking-attributable 
disease type. In the UK a total of 23,945 deaths of adults with mental disorders were 
attributable to smoking in 2010, 12,389 for men and 11,556 for women. It is estimated 
that 39% (9,280) of all deaths due to respiratory diseases and 31% (7,425) of all 
cancer deaths were attributable to smoking among people with mental disorders. In 
addition, an estimated 28% (6,758) of deaths from cardiovascular diseases and 2% 
(482) of deaths from diseases of the digestive system were attributable to smoking. 
Smoking increases the excess risk of cardiovascular death and some types of cancer 
among people with mental disorders, and results in a future productivity loss of £493 
million and £111 million, respectively.  
 
Table 7 Number of premature deaths and indirect mortality cost among people with mental disorders 
by type of smoking caused disease in UK, 2009/10 Unit of costs: £ million 
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		 Male Female All Adults 
  Deaths Costs Deaths Costs Deaths Costs 
Malignant Neoplasms 4,267 (34%) £73 (18%) 3,158 (27%)  £38 (10%) 7,425 (31%)  £111 (14%) 
Cardiovascular Diseases 3,784 (31%) £260 (63%) 2,974 (26%)  £233 (61%) 6,758 (28%)  £493 (62%) 
Respiratory Diseases 4,101 (33%) £73 (18%) 5,179 (45%)  £107 (28%) 9,280 (39%)  £180 (23%) 
Digestive Diseases 2,37 (2%) £8 (2%) 245 (2%)  £5 (1%) 482 (2%)  £13 (2%) 
Total 12,389 (100%) £415 (100%) 11,556(100%)  £383 (100%) 23,945(100%) £797 (100%) 
 
DISCUSSION 
 
Smoking rates are substantially higher in disadvantaged groups, such as people with 
mental disorders, compared with the general population [2] resulting in a much 
greater incidence of smoking-related morbidity and mortality in these groups. Among 
people with mental health disorders, smoking has historically been widely considered 
to be a self-medication mechanism, which in part explains the sustained difficulties 
faced by medical services in preventing smoking in this group [6]. This paper is to our 
knowledge the first attempt to estimate the overall economic burden due to smoking 
and smoking-related diseases among people with mental health disorders in the UK.  
 
We estimate that there are about three million people with mental disorders in the UK 
who also smoke and are hence susceptible to smoking related-disease. We estimate 
that the direct medical cost to the NHS in 2010 of treating these smokers for diseases 
caused by smoking was £719 million, and that smoking in this group also accounts for 
around 35% of work-related absenteeism due to smoking, costing £823 million in lost 
productivity, and about 34% of premature mortality, costing £797 million.   
 
Since there is little research examining the economic burden of smoking among 
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people with mental illnesses, comparisons with other studies are largely limited to 
those involving the general population. A recent study by Callum and colleagues 
employed a similar method to estimate the direct medical cost to the NHS in the 
general population [14], and using the 1996 smoking prevalence of 28.5% estimated 
the direct cost of treating smoking-related diseases to the NHS at £2.7 billion in 
England. This equates to an average annual health care cost of approximately £200 
per smoker, whilst in our study the cost amongst people with mental disorders was 
estimated around £320 per smoker. This suggests that the average direct medical costs 
were much higher in people with mental health disorders than in the general 
population.  
 
Productivity lost due to smoking by people with mental health disorders imposes 
further economic costs in addition to direct health care expenditure. A number of 
studies have demonstrated that smokers have an increased level of absenteeism from 
work in the general population [27]. The most recent study has estimated the cost of 
productivity lost due to smoking related absence to be £2.5 billion in 2010 in the UK 
[27], equivalent to approximately £280 per smoker. Results from the current study 
show an estimated £823 million of productivity lost due to absenteeism caused by 
smoking-related diseases in people with mental disorders. The average smoking-
related illness absence cost per smoker was around £260 in people with mental 
disorders. Research suggests that the indirect morbidity cost among mental health 
patients is not as high as those in the general population because of the comparatively 
lower employment rate and average earnings.  For example, among those with severe 
mental health diseases such as schizophrenia, only 9% work full time and 19% work 
part time and the weekly pay was much lower than those who do not have any mental 
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disorders (Table 4).  
 
The estimated deaths, years of life lost and economic costs of smoking in this 
population are potentially almost entirely preventable through smoking cessation and 
harm reduction interventions. Smoking cessation is one of the most cost-effective 
public health interventions, and an estimated incremental cost per quality-adjusted 
life-year (QALY) of between £221 and £9,515, which is considerably lower than the 
informal NICE threshold for cost effective NHS treatments (£20,000 per QALY) [28]. 
Data based on NHS Stop Smoking Services suggests that the cost per quitter was 
£220 in the UK in 2010/11[29], whereas the estimated average healthcare costs and 
productivity losses presented in this study was more than £650 per person annually 
due to smoking. However, the effectiveness of smoking cessation may differ in people 
with mental disorders compared to the general population due to heavy addiction to 
nicotine among people with mental disorders [6]. Further research is needed to 
explore the effectiveness and cost-effectiveness of smoking cessation in people with 
mental disorders.  
 
In this study, the proportion of current and ex-smokers among people with SMD was 
obtained from a study conducted in 1996. Thus, we conducted a sensitivity analysis to 
test the impact of variation in the smoking rate amongst people with SMDs on the 
results. The Health Improvement Network (THIN) is an electronic dataset capturing 
GP medical records from around 8 million patients across the UK. THIN data report a 
smoking prevalence in people with schizophrenia and bipolar affective disorder of 
44.6% and 36.7% respectively in 2009-10. [6] The recording of ex-smoking in THIN 
is incomplete and hence we assumed the smoking prevalence difference between the 
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1996 data used in the baseline calculation and the THIN data to be ex-smokers. The 
results of the sensitivity analysis show a slight decline in the three cost components: 
£692 million for direct medical costs, £806 million for indirect morbidity costs and 
£779 million for indirect mortality costs. 
 
The economic costs estimated above do not include the cost of accidental fires caused 
by discarded cigarettes, costs due to diseases caused by second-hand smoke exposure 
in mental health settings, or excess costs for psychotropic drug dose due to increased 
metabolism of some psychotropic medications in smokers. It is reported that the 
excess psychotropic medicine costs to the NHS due to smoking was £40 million [6]. 
On the other hand, non-smokers live longer than smokers and impose a greater burden 
on health care resources especially in later ages. However, there is evidence that in 
general population smoking constitutes an economic burden to the society  even when 
considering non-smokers longer life expectancy.[30] Further research is needed to 
examine more closely to the long-term cost of smoking and smoking cessation 
amongst people with mental disorders, incorporating the health benefits to the society 
as a whole.  
  
It is clear that smoking in people with mental disorders in the UK imposes a 
significant economic burden and therefore that the development and implementation 
of smoking cessation interventions in this group should be a high priority. This 
economic case augments the ethical and clinical imperative of addressing smoking 
more systematically and effectively in this group and is over and above the health 
benefits in terms of quality and quantity of life which are enjoyed following smoking 
cessation.  
	23	
	
WHAT THIS PAPER ADDS 
 
This study estimated the economic costs of the health effects of cigarette smoking 
amongst people with mental disorders in the UK based on the cost of illness approach. 
The avoidable costs include direct healthcare costs, indirect morbidity costs and 
indirect mortality costs due to smoking-related diseases.   
 
The result demonstrated that smoking in people with mental disorders in the UK 
imposes a significant economic burden and therefore that development and 
implementation of smoking cessation interventions in this group is a particularly high 
priority.   
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